As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Aims and scope
Molecular Brain is an open access, peer-reviewed journal that considers manuscripts on all aspects of studies on the nervous system at the molecular, cellular, and systems level providing a forum for scientists to communicate their findings.
Molecular brain research is a rapidly expanding research field in which integrative approaches at the genetic, molecular, cellular and synaptic levels yield key information about the physiological and pathological brain. These studies involve the use of a wide range of modern techniques in molecular biology, genomics, proteomics, imaging and electrophysiology.
Featured Editorial - No raw data, no science
In this series of reviews, we take a look at the molecular basis of neural disorders. The topics addressed include: iPSC technology for autism models, CaMKII dysregulation in Alzheimer's disease, migroglia in neuropathic pain, metabotropic glutamate receptors in schizophrenia, and cortical kinate receptors in anxiety.
Currently accepting Micro Reports
Micro Reports are suitable for presenting small amounts of data or research that otherwise remain unpublished, including important negative results, reproductions, or exciting findings that you wish to place rapidly into the public domain.
Find out more about how Micro Reports could be right for your research.
Announcing the launch of In Review
In partnership with Research Square, Molecular Brain is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Molecular Brain has published a series of reviews covering the molecular aspects of synaptic plasticity. This series opens with a broad, historical overview by Eric Kandel, followed by a range of reviews from eminent experts in the field
Hebb 70 Series
Celebrating Donald O. Hebb's seminal work, The Organization of Behavior, the first articles in our new thematic series are now available.
Find out more and read the published articles here.
No major experimental revisions requested. We will not request major additional experiments during the peer-review process, as we believe that high-quality data should be published promptly without unnecessary delay.
Molecular Brain is the official journal of the Association for the Study of Neurons and Diseases (AND). The AND is a not-for-profit organization for the study of mental health from a neurological perspective. The goal of AND is to enhance the quality and quantity of research and education as it pertains to the understanding and treatment of mental health issues.
“The brain is the most complex structure in the universe, yet it defines who we are. Molecular Brain is a fast, open access, online journal that publishes high quality papers and thus promotes communication among neuroscientists interested in revealing the mysteries of brain function at the molecular and cellular level."
Bong-Kiun Kaang, Editor-in-Chief, Molecular Brain
"One of the most significant driving forces in science is discovery in our daily research activity. At Molecular Brain, we believe the delay between the moment of discovery and publication should be as short as possible, but with high-quality and fair peer-review. By exploring and adopting new innovations and technology advances, I will strive to ensure Molecular Brain is the best place to publish your discovery in brain science. "
Tsuyoshi Miyakawa, Editor-in-Chief
As of June 2020, Molecular Brain is delighted to announce Professor Graham Collingridge as our new co-Editor-in-Chief.
Graham has long been at the forefront of synaptic plasticity research, and will take on the responsibility of the journal's Reviews section, previously lead by Professor Tim Bliss.
Molecular Brain is affiliated with the Association for the Study of Neurons and Disease (AND).
Annual Journal Metrics
31 days to first decision for reviewed manuscripts only
26 days to first decision for all manuscripts
78 days from submission to acceptance
17 days from acceptance to publication
706 Altmetric mentions
Molecular Brain has partnered with Publons to give you official recognition for your contribution to peer review. Create a free profile to have your reviews automatically added.